Analgesic Effect and Immunomodulation Response on

Pro-Inflammatory Cytokines Production by Scrophularia

megalantha Extract by Azadmehr, Abbas et al.
Azadmehr et al 
Trop J Pharm Res, December 2013;12 (6): 
 
935 
Tropical Journal of Pharmaceutical Research December 2013; 12 (6): 935-939 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v12i6.11 
Original Research Article 
 
 
Analgesic Effect and Immunomodulation Response on 
Pro-Inflammatory Cytokines Production by Scrophularia 
megalantha Extract  
 
Abbas Azadmehr1, Mohammad Sofiabadi1* and Reza Hajiaghaee2 
1Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, 2Department of Pharmacognosy and 
Pharmaceutics Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. 
 
*For correspondence: Email: mohasofi@yahoo.com; Tel/Fax: +982813336004 
 
Received: 27 December 2012        Revised accepted: 24 October 2013 
 
Abstract 
Purpose: The remains unknown, To determine the analgesic and anti-inflammatory activities of 
Scrophularia megalantha in male rats in order to understand the scientific basis for its trado-medicinal 
uses, especially in inflammation.   
Methods:  The extract of Scrophularia megalantha was obtained with ethanol. In order to determine 
qualitatively the chemical components of the extract, thin layer chromatography (TLC) was used. The 
analgesic activity of the extract at various doses (25, 50, 100 and 200 mg/kg, i.p) was assessed using 
formalin test while pro-inflammatory cytokines were measured by enzyme-linked immunosorbent assay 
(ELISA), respectively.  Diclofenac (5 mg/kg) was used as positive control. 
Results: Phenolic compounds, flavonoids and phenyl propanoid were present in the extract. At doses 
of 100 and 200 mg/kg, the extract showed significant analgesic effects (p < 0.05, p< 0.01) in the first 
phases of formalin test, compared with the control. At 25, 100 and 200 mg/kg doses, the extract 
reduced significantly (p < 0.05, p < 0.001, p < 0.001) pain score in the chronic phases of the formalin 
test. In addition, at 50 - 200 µg/mL of the extractm both TNF- and IL-6 proinflammatory cytokines were 
inhibited significantly (p < 0.001) on LPS-stimulated macrophages.  
Conclusion: The extract of S. megalantha exerts analgesic and anti-inflammatory activities by inhibition 
of pro-inflammatory cytokines production. This lends support for the use of the plant as an analgesic in 
traditional medicine.  
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INTRODUCTION 
 
Chronic pain is the most common symptom that 
brings a patient to the physician. Currently 
available analgesic drugs such as opiates and 
non-steroidal anti-inflammatory drug (NSAID) are 
not fully accepted due to their adverse effects. 
For example, opioids may induce physical 
dependence, tolerance and other side effects 
including respiratory depression, drowsiness, 
nausea, constipation and alterations of endocrine 
and autonomic nervous system activities. Also 
NSAIDs can aggravate peptic ulcers and cause 
hepatorenal complications. Consequently, there 
is renewed interest in new natural analgesics, 
especially of plant origin [1,2]. 
 
Inflammation plays role in the mechanism of 
pain. It can decrease pain threshold, increase 
nociceptive neuron firing rate and facilitate pain 
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transmission; these processes can augment pain 
[3,4]. On the other hand, the process of 
inflammation is necessary for healing of 
damaged tissues. In response to inflammation, a 
variety of innate immune cells such 
macrophages can be activated. However, 
uncontrolled inflammation induces tissue injury. 
Cytokine production is a primary step of the 
reaction of macrophages to inflammatory stimuli 
[5]. During inflammation, the over-production of 
inflammatory cytokines such as TNF-α, IL-6 and 
IL-1 by activated macrophages is a crucial event 
for triggering progressive stimulation of immune 
cells [6].  
 
One of the plants said to have immuno-
modulatory and anti-inflammatory effects is 
Scrophularia megalantha Boiss (Scrophularia-
ceae) [7,8]. Several species of this genus have 
been used since ancient times as folk remedies 
for ailments such as inflammatory diseases, 
scabies, eczema, psoriasis, tumors, etc. In 
addition, we have previously demonstrated the 
inhibitory effect of Scrophularia striata extract on 
nitric oxide production using in vitro and ex vivo 
models [7]. Some species in this genus have 
shown anti-inflammatory activity [8]. Therefore, 
the objective of the present study was to 
investigate the effect of the ethanol extract of the 
aerial parts of Scrophularia megalantha on pro-
inflammatory cytokines, including TNF-α and IL-6 
denerated by LPS-stimulated macrophages, and 
formalin-induced inflammatory pain in male rats. 
 
EXPERIMENTAL 
 
Plant material and preparation of extract  
 
The aerial parts of Scrophularia megalantha 
were collected from Kelardasht Region 
(Mazandaran Province) in the northern part of 
Iran, in May 2011 and air-dried at room 
temperature. The plant was identified by Mr. 
Ajani of the Department of Botany, Institute of 
Medicinal Plants (IMP) of Karaj, Iran. A voucher 
specimen (no. 1461) was deposited in the 
herbarium of the institute. The plant material was 
dried, powdered, and 100 g macerated with 80 % 
ethanol (900 ml) for 3 days with three changes of 
the solvent. The resulting extract was filtered and 
evaporated under vacuum to a dry powder (yield, 
12.1 %). The plant extract was dissolved in 
dimethylsulfoxide (DMSO) to contain 0.1 %w/v of 
the extract and used at appropriate 
concentrations. 
 
Phytochemical assay 
 
In order to recognize chemical components of 
the extract, thin layer chromatography (TLC) was 
used. A variety of indicators including vanillin 
sulfuric acid; ferric chloride and natural product 
polyethylene glycol were used in this assay. The 
indictors were sprayed on prepared thin layers of 
fractions and observed at 260 and 280 nm 
wavelength under UV light. 
 
Animals 
 
Rats (230 – 250 g) were purchased from the 
Pasteur Institute of Iran (Tehran, Iran). All the 
animal experiments were approved by and 
performed according to the guidelines of the 
Ethical Committee of Cellular and Molecular 
Research Center (CMRC) of Qazvin University of 
Medical Sciences (approval ref no. 11.3.2011-
CN157). The animals were maintained under 
standard laboratory conditions of temperature 
(23 ± 2 oC) and light/dark cycle of 12 h/12 h, and 
received standard rat chow and water ad libitum.  
 
Formalin test in rats  
 
Analgesic activity was performed using formalin 
test as described by Dubuisson and Dennis  [9]. 
Briefly, the rats were divided into 6 groups, each 
consisting of seven rats. The rats were moved to 
the test room 1 h before the experiment and 
acclimatized for 30 min in an acrylic observation 
chamber (30 cm in diameter and height) prior to 
intraperitoneal administration of the extract (25, 
50,100 and 200 mg/kg) or diclofenac-Na (5 
mg/kg) or normal saline (1 ml), Thirty minutes 
later, 50 μL of 2 % formalin was injected 
subcutaneously into the plantar surface of the 
right hind paw with a 30-gauge needle. Each rat 
was then immediately returned to the observation 
chamber, and pain behavior recorded. Pain 
behavior was scored (at 1-min interval for 60 
min) as follows: 0, the injected paw was not 
favored; 1, the injected paw had little or no 
weight placed on it; 2, the injected paw was 
elevated and not in contact with any surface; and 
3, the injected paw was licked or bit. The 
behavioral response of each rat during the early 
phase (1 – 7 min) and the late phase (15 – 60 
min) was separately evaluated [9].   
 
Isolation of peritoneal macrophages from rats 
 
The rats were killed by cervical dislocation and 
peritoneal macrophages were harvested 
immediately by lavaging with ice cold sterile 
phosphate buffer saline (PBS). The cells were 
washed twice and plated in RPMI 1640 medium 
(Sigma Chemical Co) containing 10 % fetal 
bovine serum (Gibco), 100 U/ml penicillin and 
100 µg/ ml streptomycin (Sigma Chemical Co), 
and incubated for 2 h at 37 °C in 5 % CO2 
humidified incubator. Non-adherent cells were 
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removed by gently washing with PBS and freshly 
prepared medium was added. Cell viability was 
checked by trypan blue exclusion technique. An 
aliquot of the cell suspension was mixed with an 
equal volume of 0.4 %w/v trypan blue in PBS 
and incubated for 10 min. The viability of the 
macrophages was > 98 %. 
 
Measurement of pro-inflammatory cytokines  
 
LPS (1 µg/ml) stimulated peritoneal 
macrophages were co-incubated with extract (10 
– 200 µg/ml) or medium alone for 24 h. The 
supernatant was obtained by centrifugation at 
2500 rpm for 20 min and assayed for TNF-α and 
IL-6 using ELISA kits (Bio-Source, Camarillo, CA, 
USA) according to the manufacturer’s 
instructions. 
 
Statistical analysis  
 
Data are presented as mean ± standard 
deviation (SD). Statistical analyses were 
performed by one-way analysis of variance 
(ANOVA) to express difference among the 
groups followed by Bonferroni post hoc test. All 
analyses were performed using SPSS software, 
version 16. Differences were considered 
statistically significant at p < 0.05. 
 
RESULTS 
 
Chemical components of the extract 
 
Phytochemical assay by thin layer 
chromatography showed the presence of 
phenolic compounds, flavonoids and phenyl 
propanoids in S. megalantha extract. 
 
S. megalantha extract reduced pain 
symptoms  
 
Both acute (early) and chronic (late) phases of 
pain were observed in all groups after formalin 
injection (Fig 1).  
 
In the acute phase, the extract decreased dose-
dependently pain symptoms in comparison to 
control that was significant at 100 and 200 mg/kg 
dose (p < 0.05, p < 0.01)  as shown in Fig 2A. 
The positive control, diclofenac-Na (5 mg/kg), 
significantly inhibited formalin-induced pain in the 
late phase (p < 0.01) (Fig 2B); however, there 
was no inhibition in the early phase (Fig 2A).  
 
The extract significantly inhibited the late phase 
of formalin-induced pain, compared with control 
(Fig 2B). The inhibitory effect of extract (100 and 
200 mg/kg) was stronger than that of the positive 
control, diclofenac-Na (5 mg/kg) (p < 0.001). 
 
 
Time after formalin injection (min) 
 
Fig 1: Effect of S. megalantha extract (25, 50, 100, 
200 mg/kg, i.p.) and diclofenac (5 mg/kg, i.p.) on 2 % 
formalin-induced inflammatory pain in male rats. Data 
are presented as mean ± SD (n = 7) (● = control;  = 
diclofenac; ▲= Extract 25 mg) 
 
Fig 2: Effect of S. megalantha (25, 50, 100 and 
200 mg/kg, i.p.) and diclofenac (5 mg/kg, i.p.) on 2 % 
formalin-induced inflammatory pain (early and late) 
phases in male rats. The extract reduced pain scores 
dose dependently in early phase 2A (0 – 5 min) and 
late phase 2B (15 – 40 min). Data are represented as 
mean ± SD (n = 7). *p < 0.05, **p < 0.01, ***p < 0.001 
compared with the control group  
 
S. megalantha extract reduced LPS- 
stimulated proinflammatory cytokines 
production in peritoneal macrophages 
 
The effect of co-culture of LPS and extract for 24 
h on the release of TNF-α and IL-6 pro-
inflammatory cytokines into the medium is shown 
in Figs 3 and 4. Rat macrophages responded 
strongly to the addition of LPS by releasing TNF-
α and IL-6 into the supernatant medium. 
Treatment of the cells with S. megalantha extract 
attenuated, in a concentration-dependent 
manner, the production of both pro-inflammatory 
cytokines by macrophages. The extract 
3 
 
2 
 
1 
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significantly (p < 0.001) inhibited the production 
of both cytokines by LPS-activated macrophages 
in the concentration range of 50 - 200 µg/ml. The 
inhibition of TNF-α and IL-6 cytokines at the 
concentration of 200 µg/ml was approximately 65 
and 25 % LPS only treated cells, respectively. 
Thus, inhibition of TNF-α was higher than of IL-6 
after treatment of the macrophages with extract.  
 
 
Fig 3: Effect of S. megalantha extract on LPS- 
stimulated TNF-α pro-inflammatory cytokine produc-
tion in rat peritoneal macrophages. The extract 
significantly (p < 0.001) inhibited the production of 
TNF-α cytokine by LPS activated macrophages. Data 
are presented as mean ± SD. 
 
DISCUSSION 
 
S. megalantha is an important genus consisting 
of about 60 species in the Iran [10]. Most species 
belonging to Scrophularia genus have been used 
for anti-inflammatory therapy in folk medicine. A 
pervious study showed that some spices of 
Scrophularia have various flavonoids with anti-
inflammatory properties; this study also indicates 
that S. megalantha extract contains flavonoids 
[11].  
 
Phenylpropanoids play multiple important 
biologic roles, for example, anti-inflammatory 
action by reducing pro-inflammatory stimuli [12]. 
On the other hand, several reviews have 
reported the anti-inflammatory activity of phenols, 
attributing their properties not only to antioxidant 
capacity, but also to pro-inflammatory mediator 
modulation [13].  Our results show that phenolic 
compounds, flavonoids and phenyl propanoids 
are present in S. megalantha extract. Therefore, 
it is probable that the extract would exert 
analgesic and anti- inflammatory actions.  
 
 
Fig 4: Effect of S. megalantha extract on LPS- 
stimulated IL-6 pro-inflammatory cytokine production 
in rat peritoneal macrophages.  
 
The present results indicate that the ethanol 
extract of S. megalantha reduced symptoms of 
pain dose-dependently in both acute and chronic 
pain phases. This suggests that the extract 
exerts its analgesic action by both peripheral and 
central mechanisms. When formalin is injected 
into the footpad of an animal, it produces two 
phases of nociceptive behavior that are 
separated by a short period of quiescence in 
which there is no apparent pain. The first or 
acute phase typically occurs in the first 5 min 
while the second starts from 15 min and lasts 
about 40 - 60 min after injection. The early phase 
seems to be caused mainly by direct activation of 
both low-threshold mechanoreceptors and 
nociceptive primary afferent fibers due to 
peripheral stimulus. The late phase, also called 
the tonic phase, appears to be dependent on the 
combination of inflammatory reaction in the 
peripheral tissue and functional changes at some 
level of the central nervous system, spatially in 
the dorsal horn of the spinal cord, generally 
called central mechanisms [14].  
 
In the present study, we observed more intense 
analgesic effect on the late (inflammatory) phase 
in the formalin test and the results show that the 
extract has potent analgesic effect. Therefore, it 
contains compounds that act peripherally and 
reduce inflammation [15].  In addition, our results 
indicate that the anti-nociceptive effect of the 
extract may be due to its anti-inflammatory effect.  
Pro-inflammatory cytokines, such as interleukin-6 
(IL-6), is a cytokine initially indentified as T-cell 
derived factor regulating B-cell growth and 
differentiation. Furthermore, deregulation of IL-6 
production has been implicated in a variety of 
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inflammatory diseases [16]. Pro-inflammatory 
cytokines such as IL-1 and tumor necrosis factor-
α (TNF- α) markedly stimulate IL-6 production 
[17]. These mediators are able to recruit 
leukocytes, such as neutrophils, as reported for 
several experimental models [18,19]. In the 
present study, the levels of TNF-α and IL-6 were 
significantly decreased when treated with the 
extract. Thus, a putative anti-inflammatory 
mechanism could be associated with the degree 
of inhibition of pro-inflammatory mediators, such 
as TNF-α and IL-6. Our results indicate that the 
extract exhibited antinociceptive and anti-
inflammatory activities. Although the anti-
inflammatory mechanisms of S.megalantha are 
likely linked to the decrease in IL-6 and TNF-α 
pro-inflammatory cytokines, the effect of the 
extract on other inflammatory mediators is also 
essential.  
 
CONCLUSION  
 
Based on the findings of the present study, the 
ethanol extract of S. megalantha possesses 
analgesic and anti-inflammatory potentials. 
However, further studies are necessary to 
determine precisely the underlying mechanisms 
of these actions as well as to isolate the active 
compound(s) responsible for the activities. 
 
ACKNOWLEDGEMENT   
 
This study was supported by Cellular and 
Molecular Research Center of Qazvin University 
of Medical Sciences, Qazvin, Iran and Institute of 
Medicinal Plants (IMP) of Karaj, Iran. 
 
REFERENCES 
 
1. Kimura K, Lau Cs, Louw J, Sollano J, Triadiafalopulos G, 
Xiao Sd, Brooks P. Non-steroidal anti-inflammatory 
drug toxicity in the upper gastrointestinal tract. J 
Gastroenterol Hepatol. 2000; 15(3): G58-68. 
2. Berger AC, Whistler JL. How to design an opioid drug that 
causes reduced tolerance and dependence.Ann 
Neurol. 2010; 67(5): 559-569. 
3. Yerima. M, Magaji MG, Yaro AH, Tanko Y, Mohammed 
MM.  Analgesic and anti-inflammatory activities of 
the methanolic leaves extract of securinega virosa 
(euphorbiaceae). Nig  Journ  Pharm Sci. 2009; 8 
(1): 47–53. 
4. Gatta L, Piscitelli F, Giordano C, Boccella S, Lichtman A, 
Maione S, Di Marzo V. Discovery of  Prostamide 
F2α and Its Role in Inflammatory Pain and Dorsal 
Horn Nociceptive Neuron Hyperexcitability. PLoS 
ONE, 2012; 7(2): e31111. 
5. Calandra T, Roger T. Macrophage migration inhibitory 
factor: a regulator of innate immunity. Nat Rev 
Immunol . 2003; 3(10): 791-800. 
6. Wu GJ, Chen TL, Ueng YF, Chen RM. Ketamine inhibits 
tumor necrosis factor-a and interleukin-6 gene 
expressions in lipopolysaccharide-stimulated 
macrophages through suppression of toll-like 
receptor 4-mediated c-Jun N terminal kinase 
phosphorylation and activator protein-1 activation. 
Toxicol Appl Pharmacol. 2008 ; 228(1): 105–113. 
7. Azadmehr A, Afshari A, Baradaran B, Hajiaghaee R, 
Rezazadeh S, Monsef-Esfahani H. Suppression of 
nitric oxide production in activated murine peritoneal 
macrophages in vitro and ex vivo by Scrophularia 
striata ethanolic extract. J Ethnopharmacol. 2009; 
124: 166-169. 
8. Díaz AM, Abad MJ, Fernández L, Silván AM, De Santos 
J, Bermejo P. Phenylpropanoid glycosides from 
Scrophularia scorodonia: in vitro anti-inflammatory 
activity. Life Sci. 2004; 74(20): 2515-2526. 
9. Dubuisson D, Dennis SG. The formalin test: a quantitative 
study of the analgesic effects of morphine, 
meperidine, and brain stem stimulation in rats and 
cats. Pain 1977; 4(2): 161-174. 
10. Attar F, Joharchi M R, Nowrouzi M, Hatami A. New 
species of Scrophularia L (Scrophulariaceae) from 
Iran. Iran  J  Bot. 2006; 12 (2): 193-202. 
11. García D, Fernández A, Sáenz T, Ahumada C. 
Antiinflammatory effects of different extracts and 
harpagoside isolated from Scrophularia 
frutescens L. Farmaco. 1996; 51(6): 443-446. 
12. Korkina L, Kostyuk V, De Luca C, Pastore S. Plant 
phenylpropanoids as emerging anti-inflammatory 
agents. Mini Rev Med Chem. 2011; 11(10): 823-
835. 
13. Costa G, Francisco V, Lopes MC, Cruz MT, Batista MT. 
Intracellular signaling pathways modulated by 
phenolic compounds: application for new anti-
inflammatory drugs discovery. Curr Med Chem. 
2012; 19(18): 2876-2900. 
14. Abbott FV, Franklin KB, Westbrook RF: The formalin test: 
scoring properties of the first and second phases 
of the pain response in rats. Pain .1995; 60(1): 
91-102. 
15. Walker JS. Anti-inflammatory effects of opioid. Adv Exp 
Med Biol. 2003; 521: 148-160. 
16. Hirano T, Akira S, Taga T, Kishimoto T. Biological and 
clinical aspects of interleukin 6. Immunol Today. 
1990; 11(12): 443-449. 
17. Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, 
Cayphas S, Vink A, Billiau A, Van Snick J . 
Identification of the human 26 kd protein, 
interferon f32 (IFN fl2), as a B cell 
hybridoma/plasmacytoma growth factor induced 
by interleukin1 and tumor necrosis factor. J Exp 
Med .1987; 165: 914-919. 
18. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino 
MH, Manning PT, Currie MG. Nitric oxide: a key 
mediator in the early and late phase of 
carrageenan-induced rat paw inflammation. Br J 
Pharmacol. 1996; 118(4): 829-838. 
19.  Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell 
D. Cytokine profiles during carrageenan-induced 
inflammatory hyperalgesia in rat muscle and hind 
paw. J Pain 2007; 8(2): 127-136.  
 
